| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 10 |
| 1 | PREDNISOLONE | 10 |
| 2 | PREDNISOLONE ORAL | 10 |
| 3 | PREDNISOLONE ORAL SOLUTION | 10 |
| 4 | CARBOPLATIN | 9 |
| 5 | TOCILIZUMAB | 9 |
| 6 | GEMCITABINE HYDROCHLORIDE | 8 |
| 7 | METHYLPREDNISOLONE | 8 |
| 8 | GEMCITABINE | 6 |
| 9 | CYCLOSPORINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 1 | GLUTATHIONE | 1 | 0.0006 |
| 2 | DARUNAVIR 600 MG | 2 | 0.0003 |
| 3 | RIFAMPIN | 3 | 0.0002 |
| 4 | GANCICLOVIR SODIUM | 2 | 0.0002 |
| 5 | GEMCITABINE HYDROCHLORIDE | 8 | 0.0001 |
| 6 | DARUNAVIR | 2 | 0.0001 |
| 7 | LIDOCAINE PATCH 5% | 1 | 0.0001 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 9 | AMIKACIN | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Rifamycin Antibacterial [EPC] | 3 | 0.0001 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 9 | 0.0001 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 10 | 0.0001 |
| 5 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Aminoglycoside Antibacterial [EPC] | 2 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 12 | 0.0000 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 5 | 0.0000 |
| 9 | Nucleoside Analog Antiviral [EPC] | 2 | 0.0000 |